T0	Participants 56 75	patients with COPD:
T1	Participants 487 513	patients with stable COPD.
T2	Participants 524 670	20 ex-smoking COPD patients with post-bronchodilator forced expiratory volume in one second (FEV(1)) >1.20 L and FEV(1)/forced vital capacity <70%
T3	Participants 1313 1382	patients with chronic obstructive pulmonary disease in a stable phase
T4	Participants 1559 1586	inflammatory lung diseases.